Advanced Artwork and Labelling Production Analytics White Paper

Pharmaceutical Artwork Departments can accelerate business impact
with Advanced Artwork and Labelling Production Analytics (AALPA)

As global healthcare markets become more cost constrained, pharmaceutical companies are leveraging the data generated across all aspects of the supply chain to drive decision making and gain competitive advantage over their rivals.

It has been estimated that operating efficiencies achieved by enhancing processes or eliminating inefficiencies identified using Advanced Artwork and Labelling Production Analytics (AALPA) can range from between 50% to 70%. This presents a concrete opportunity for pharmaceutical companies to increase productivity, reinforce compliance, accelerate time-to-market and remove unwanted waste from the supply chain.

Read our guide to find out how ALPA can assist Pharmaceutical Artwork Departments accelerate business impact: